1. Intraperitoneal bevacizumab for control of malignant ascites due to advanced-stage gastrointestinal cancers: A multicentre double-blind, placebo-controlled phase II study – AIO SUP-0108. (August 2016) Authors: Jordan, K.; Luetkens, T.; Gog, C.; Killing, B.; Arnold, D.; Hinke, A.; Stahl, M.; Freier, W.; Rüssel, J.; Atanackovic, D.; Hegewisch-Becker, S. Journal: European journal of cancer Issue: Volume 63(2016) Page Start: 127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗